Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORESA: T89 (Dantonic) in Stable Angina
NCT03789552Phase 3Recruiting
- Sponsor
- Tasly Group
- Start
- Aug 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Compound Danshen in angina pectoris, sponsored by Tasly Group. Started Aug 2019; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT03789552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789552.